High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
Clinical trial NCT01205035 · COMPLETED
Trial details
- NCT number
- NCT01205035
- Sponsor
- Eye Center of Northern Colorado, P.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-10-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.